These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27735925)

  • 1. Early manifestations of type 1 Gaucher disease in presymptomatic children diagnosed after parental carrier screening.
    Yang AC; Bier L; Overbey JR; Cohen-Pfeffer J; Desai K; Desnick RJ; Balwani M
    Genet Med; 2017 Jun; 19(6):652-658. PubMed ID: 27735925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India.
    Sheth J; Pancholi D; Mistri M; Nath P; Ankleshwaria C; Bhavsar R; Puri R; Phadke S; Sheth F
    BMC Med Genet; 2018 Oct; 19(1):178. PubMed ID: 30285649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified.
    Huang Y; Jia X; Tang C; Liu S; Sheng H; Zhao X; Zeng C; Liu L
    Clin Chim Acta; 2020 Jul; 506():22-27. PubMed ID: 32165122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes.
    Balwani M; Fuerstman L; Kornreich R; Edelmann L; Desnick RJ
    Arch Intern Med; 2010 Sep; 170(16):1463-9. PubMed ID: 20837833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N370S/R496H genotype in type 1 Gaucher disease - Natural history and implications for pre symptomatic diagnosis and counseling.
    Zeid N; Stauffer C; Yang A; Naik H; Fierro L; Ganesh J; Balwani M
    Mol Genet Metab Rep; 2020 Mar; 22():100567. PubMed ID: 32042592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry.
    Fairley C; Zimran A; Phillips M; Cizmarik M; Yee J; Weinreb N; Packman S
    J Inherit Metab Dis; 2008 Dec; 31(6):738-44. PubMed ID: 18979180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A/B and C.
    Ries M; Schaefer E; Lührs T; Mani L; Kuhn J; Vanier MT; Krummenauer F; Gal A; Beck M; Mengel E
    J Inherit Metab Dis; 2006 Oct; 29(5):647-52. PubMed ID: 16972172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity.
    Stein P; Yang R; Liu J; Pastores GM; Mistry PK
    J Inherit Metab Dis; 2011 Apr; 34(2):429-37. PubMed ID: 21290183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A disease severity scoring system for children with type 1 Gaucher disease.
    Kallish S; Kaplan P
    Eur J Pediatr; 2013 Jan; 172(1):39-43. PubMed ID: 22992811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease.
    Andrade-Campos M; Alfonso P; Irun P; Armstrong J; Calvo C; Dalmau J; Domingo MR; Barbera JL; Cano H; Fernandez-Galán MA; Franco R; Gracia I; Gracia-Antequera M; Ibañez A; Lendinez F; Madruga M; Martin-Hernández E; O'Callaghan MDM; Del Soto AP; Del Prado YR; Sancho-Val I; Sanjurjo P; Pocovi M; Giraldo P
    Orphanet J Rare Dis; 2017 May; 12(1):84. PubMed ID: 28468677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised recommendations for the management of Gaucher disease in children.
    Kaplan P; Baris H; De Meirleir L; Di Rocco M; El-Beshlawy A; Huemer M; Martins AM; Nascu I; Rohrbach M; Steinbach L; Cohen IJ
    Eur J Pediatr; 2013 Apr; 172(4):447-58. PubMed ID: 22772880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical phenotype and genotype of Gaucher disease in 14 children].
    Sun XY; Xue Y; Wang YP; Huang J; Lin RF; Kang MY; Fang YJ
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):527-532. PubMed ID: 35658357
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison and clinical application of two methods for determination of plasma chitotriosidase activity].
    Wang Y; Zhang HW; Ye J; Qiu WJ; Han LS; Gu XF
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):834-8. PubMed ID: 23302614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.
    El-Beshlawy A; Tylki-Szymanska A; Vellodi A; Belmatoug N; Grabowski GA; Kolodny EH; Batista JL; Cox GF; Mistry PK
    Mol Genet Metab; 2017; 120(1-2):47-56. PubMed ID: 28040394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene.
    Lepe-Balsalobre E; Santotoribio JD; Nuñez-Vazquez R; García-Morillo S; Jiménez-Arriscado P; Hernández-Arévalo P; Delarosa-Rodríguez R; Guerrero JM; Macher HC
    Clin Chem Lab Med; 2020 Jun; 58(12):2017-2024. PubMed ID: 32589593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized long-term enzyme therapy for Gaucher disease type 1 in Slovenia.
    Benedik-Dolničar M; Kitanovski L
    Pediatr Int; 2011 Dec; 53(6):1018-22. PubMed ID: 21883686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and psychological functioning of pediatric and young adult patients with Gaucher disease, type 1.
    Alioto AG; Gomez R; Moses J; Paternostro J; Packman S; Packman W
    Am J Med Genet A; 2020 May; 182(5):1130-1142. PubMed ID: 32125090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gaucher disease--one of the possible causes of splenomegaly--case report].
    Sokołowska B; Skomra D; Czartoryska B; Tomczak W; Tylki-Szymańska A; Repelewska M; Drop A; Gromek T
    Pol Arch Med Wewn; 2004 Sep; 112(3):1107-12. PubMed ID: 15727093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier screening for Gaucher disease in couples of mixed ethnicity.
    Wallerstein R; Starkman A; Jansen V
    Genet Test; 2001; 5(1):61-4. PubMed ID: 11336404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling.
    Rana HQ; Balwani M; Bier L; Alcalay RN
    Genet Med; 2013 Feb; 15(2):146-9. PubMed ID: 22935721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.